La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Apyx Medical Gestione
Gestione criteri di controllo 3/4
Apyx Medical's CEO is Charlie Goodwin, appointed in Dec 2017, has a tenure of 6.67 years. total yearly compensation is $1.26M, comprised of 38.2% salary and 61.8% bonuses, including company stock and options. directly owns 0.26% of the company’s shares, worth $118.80K. The average tenure of the management team and the board of directors is 5.6 years and 6.5 years respectively.
Informazioni chiave
Charlie Goodwin
Amministratore delegato
US$1.3m
Compenso totale
| Percentuale dello stipendio del CEO | 38.2% |
| Mandato del CEO | 6.7yrs |
| Proprietà del CEO | 0.3% |
| Durata media del management | 5.6yrs |
| Durata media del Consiglio di amministrazione | 6.5yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Apyx Medical Corporation (NASDAQ:APYX) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Aug 07
We Discuss Why Apyx Medical Corporation's (NASDAQ:APYX) CEO Compensation May Be Closely Reviewed
Aug 01Is Apyx Medical (NASDAQ:APYX) Using Debt In A Risky Way?
Jun 19Revenues Working Against Apyx Medical Corporation's (NASDAQ:APYX) Share Price Following 25% Dive
Apr 18Apyx Medical Corporation (NASDAQ:APYX) Analysts Just Slashed This Year's Estimates
Mar 26Take Care Before Diving Into The Deep End On Apyx Medical Corporation (NASDAQ:APYX)
Feb 16Is Apyx Medical (NASDAQ:APYX) A Risky Investment?
Sep 14Does Apyx Medical (NASDAQ:APYX) Have A Healthy Balance Sheet?
Jun 07Forecast: Analysts Think Apyx Medical Corporation's (NASDAQ:APYX) Business Prospects Have Improved Drastically
Mar 21Here's Why We're Watching Apyx Medical's (NASDAQ:APYX) Cash Burn Situation
Dec 14We're Not Very Worried About Apyx Medical's (NASDAQ:APYX) Cash Burn Rate
Aug 30Apyx Medical GAAP EPS of -$0.16 beats by $0.03, revenue of $10.3M misses by $0.26M
Aug 11Apyx Medical gets FDA nod for Renuvion's use in improving loose skin on neck, chin
Jul 18Companies Like Apyx Medical (NASDAQ:APYX) Are In A Position To Invest In Growth
May 26Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$28m |
| Mar 31 2024 | n/a | n/a | -US$23m |
| Dec 31 2023 | US$1m | US$483k | -US$19m |
| Sep 30 2023 | n/a | n/a | -US$15m |
| Jun 30 2023 | n/a | n/a | -US$16m |
| Mar 31 2023 | n/a | n/a | -US$21m |
| Dec 31 2022 | US$2m | US$483k | -US$23m |
| Sep 30 2022 | n/a | n/a | -US$19m |
| Jun 30 2022 | n/a | n/a | -US$18m |
| Mar 31 2022 | n/a | n/a | -US$16m |
| Dec 31 2021 | US$2m | US$450k | -US$15m |
| Sep 30 2021 | n/a | n/a | -US$15m |
| Jun 30 2021 | n/a | n/a | -US$14m |
| Mar 31 2021 | n/a | n/a | -US$15m |
| Dec 31 2020 | US$2m | US$450k | -US$12m |
| Sep 30 2020 | n/a | n/a | -US$16m |
| Jun 30 2020 | n/a | n/a | -US$16m |
| Mar 31 2020 | n/a | n/a | -US$16m |
| Dec 31 2019 | US$2m | US$450k | -US$20m |
| Sep 30 2019 | n/a | n/a | -US$18m |
| Jun 30 2019 | n/a | n/a | -US$15m |
| Mar 31 2019 | n/a | n/a | -US$14m |
| Dec 31 2018 | US$1m | US$400k | -US$11m |
| Sep 30 2018 | n/a | n/a | -US$10m |
| Jun 30 2018 | n/a | n/a | -US$12m |
| Mar 31 2018 | n/a | n/a | -US$15m |
| Dec 31 2017 | US$2m | US$15k | -US$14m |
Compensazione vs Mercato: La retribuzione totale di Charlie ($USD 1.26M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 680.04K ).
Compensazione vs guadagni: Charlie's compensation has been consistent with company performance over the past year.
AMMINISTRATORE DELEGATO
Charlie Goodwin (57 yo)
6.7yrs
Mandato
US$1,261,470
Compensazione
Mr. Charles D. Goodwin II, also known as Charlie, has been Chief Executive Officer and Director of Apyx Medical Corporation (formerly known as Bovie Medical Corporation) since December 15, 2017 and serves...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 6.7yrs | US$1.26m | 0.26% $ 118.8k | |
| CFO, Treasurer & Secretary | less than a year | US$445.95k | 0.023% $ 10.3k | |
| Senior Vice President | 12.6yrs | US$538.31k | 1.32% $ 602.6k | |
| Executive Vice President | 5.6yrs | US$746.27k | 0% $ 0 | |
| Executive Chairman | less than a year | Nessun dato | 5.04% $ 2.3m |
5.6yrs
Durata media
55yo
Età media
Gestione esperta: APYX's management team is seasoned and experienced (5.6 years average tenure).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 6.7yrs | US$1.26m | 0.26% $ 118.8k | |
| Executive Chairman | less than a year | Nessun dato | 5.04% $ 2.3m | |
| Independent Director | 13.4yrs | US$114.06k | 0.079% $ 36.3k | |
| Lead Independent Director | 13.4yrs | US$162.56k | 0.12% $ 56.6k | |
| Member of Medical Advisory Board | 5.1yrs | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | no data | US$9.30k | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Independent Vice-Chairman of the Board | 10.1yrs | US$144.06k | 0% $ 0 | |
| Independent Director | 5yrs | US$116.56k | 0% $ 0 | |
| Independent Director | 6.4yrs | US$106.56k | 0.22% $ 101.9k | |
| Member of Medical Advisory Board | 7.6yrs | Nessun dato | Nessun dato | |
| Member of Medical Advisory Board | 6.3yrs | Nessun dato | Nessun dato |
6.5yrs
Durata media
68yo
Età media
Consiglio di amministrazione esperto: APYX's board of directors are considered experienced (6.5 years average tenure).